Maynard Um
-
-
-
-
-
-
-
William Blair Downgrades Arcellx Inc. (ACLX) to Market Perform
-
-
-
-
-
-
-
Arcellx (ACLX) Reiterated at Buy by Stifel: Still 'a Core SMid-Cap Holding'
-
-
-
-
-
-
-
Arcellx reports positive trial data for multiple myeloma treatment
-
-
-
-
-
-
-
Stifel Starts Arcellx Inc. (ACLX) at Buy
-
-
-
-
-
-
-
Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
-
-
-
-
-
-
-
Arcellx Inc. (ACLX) PT Raised to $112 at BofA Securities
-
-
-
-
-
-
-
Arcellx Inc. (ACLX) PT Raised to $100 at BofA Securities
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

